Mission BioCapital
Jennifer Griffin, PhD is a Partner in the Cambridge office where she focuses on fund strategy and investor relations. Jennifer has spent the last 10+ years accelerating early-stage life science companies through direct investing, as well as creating ecosystems for them to thrive. As a VP at the Massachusetts Life Sciences Center (MLSC), she designed and executed the Commonwealth’s investment strategy with a particular focus on developing underserved and underrepresented markets and talent within the industry. Before this, she served as a management and strategy consultant at Back Bay Life Science Advisors. She began her career as a licensing professional at MIT’s Technology Licensing Office working with faculty, entrepreneurs, and investors to commercialize early-stage life science innovations.
Jennifer holds a B.S. in Microbiology from the University of Massachusetts Amherst and a Ph.D. in Biomedical Sciences from the University of Massachusetts Medical School, where she studied the genetic basis of mycobacterial cholesterol utilization.
This person is not in any offices
Mission BioCapital
Mission BioCapital is dedicated to helping entrepreneurial scientists create successful companies. They do this because they believe that startups are the most efficient engine for positive change. The passion and purpose that entrepreneurs bring turn ideas into solutions. These small companies take on oversized problems like chronic diseases and global environmental challenges, and with seemingly inadequate resources they succeed.